Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-012598
Filing Date
2024-04-01
Accepted
2024-04-01 21:41:26
Documents
3
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3894
2 ex24-2.htm EX-24.2 938
3 ex24-2_001.jpg GRAPHIC 323211
  Complete submission text file 0001493152-24-012598.txt   451767
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Issuer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CURAXIS 1004 CHAGFORD WAY RALEIGH NC 27614
Business Address
WRIGHT TIMOTHY R (Reporting) CIK: 0001288245 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12555 | Film No.: 24812025